SuperworthMirum Pharmaceuticals market cap MIRM
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $5.2B
- Highest close in our data
- $7.7B
- Jul 2026
Mirum Pharmaceuticals is worth $5.2B at the close on Oct 23, 2026, at $80.39 a share.
That is up 48% over the last year and up 977% over five years.
Its highest close in our data was $7.7B in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $5.2B | $4B | $7.7B | +28% |
| 2025 | $4.1B | $1.9B | $4.1B | +104% |
| 2024 | $2B | $1.1B | $2.2B | +45% |
| 2023 | $1.4B | $734.1M | $1.6B | +91% |
| 2022 | $719M | $476.7M | $964.2M | +47% |
| 2021 | $488.7M | $406.6M | $626.6M | +9% |
| 2020 | $449M | $287.9M | $654.5M | −25% |
| 2019 | $595.4M | $162.5M | $595.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Mirum Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| MIRMMirum Pharmaceuticals | $5.2B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| INDVIndivior Pharmaceuticals | $4.1B |
| ARQTArcutis Biotherapeutics | $3.9B |
| LQDALiquidia | $3.8B |
| ALKSAlkermes plc. | $7.3B |
| OGNOrganon | $3.6B |
| TGTXTG Therapeutics | $8.3B |
| PTGXProtagonist Therapeutics | $9B |
| Peer median | $6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Mirum Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.